blindness glp 1 SURGE IN GLP-1 DRUGS LIKE OZEMPIC SPARKS THOUSANDS OF LAWSUITS OVER ALLEGED SIDE EFFECTS The medications, initially for type 2 diabetes, have driven widespread off-label weight-loss use amid reported gastrointestinal injuries and GLP-1 NAION Vision Loss Lawsuit
Description
References + Disclaimer World Health Organization: WHO

& Huestis, M

plantarum KY1032 a multi-strain blend of L

[7] [8] Preoperative assessment should include specific inquiry about GLP-1 agonist use, and consideration of gastric ultrasound may be appropriate in certain cases

3 combining codes into themes